Delivery Order SPE2DB20D3103-SPE2DB25FM5H4

Award Date 1/30/25
Potential Completion Date 1/31/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,330.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,565,081,308 units of Acetaminophen 1,000mg/100ml vials, with a period of performance through July 8, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award, valued at $1,290.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of ACETAMINOPHEN 1000MG/100ML BAG 100ML, a pharmaceutical product. The contract has an ultimate completion date of February 10, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,182.60, is for the delivery of 4563153592 ! ACETAMINOPHEN 1000MG/100ML BAG 100ML. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a $1,660.94 delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,354,292 units of Acetaminophen 1,000mg/100ml vials. This contract does not have a set-aside designation and has an ultimate completion date of August 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $5,380.72 firm fixed-price contract is for the supply of 4565936188 - ACETAMINOPHEN 1,000MG/100ML VL 100ML, a pharmaceutical product. The contract has a completion date of September 26, 2024 and was awarded on September 25, 2024. It is not a set-aside contract. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award, valued at $1,507.92, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award was made under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The specific...
This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $4,571.78 firm fixed-price delivery order is for the supply of 4,567,197,845 units of acetaminophen 1,000mg/100ml vials. The contract has an ultimate completion date of February 10, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly within...
This federal contract award, valued at $1,001.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier. The contract is a delivery order for the supply of ACETAMINOPHEN-COD 4 TABLET 100S, with an ultimate completion date of September 11, 2024. This contract is not set aside and is a firm fixed-price type. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts to provide a wide range of...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp covers the delivery of acetaminophen 1,000mg/100mL vials. The $3,041.05 firm fixed-price delivery order has a completion date of December 11, 2024 and is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,853.86 firm-fixed-price delivery order is for the supply of 4,566,405,085 units of acetaminophen 1,000mg/100ml vials. The contract has an ultimate completion date of November 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM5H4
    Delivery Order

This federal contract award, valued at $1,614.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACETAMINOPHEN 325 MG TABLET 1000S, a common pharmaceutical product, with an ultimate completion date of January 31, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/1/25, 10:26 AM